Totale pubblicazioni:  228     Indicizzate su Pubmed: 131      Libri, capitoli in libri e monografie: 12

  1. Negosanti M., Bettoli V., Valenti L., Patrone P., Celasco G., Valutazione Clinica sull’utilità dell’impiego del 5,7 –dicloro-8-idrossiclorochina (clorossina) in associazione con il betametasone 17- benzoato nel trattamento topico di dermopatie cortisono-sensibili infette. Giorn.It.Derm.Vener.1985:120; XVII-XXIII.
  2. Bonelli U., Passarini B., Bettoli V. Contributo alla conoscenza della orticaria vasculitica.Giorn.It.Derm.Vener.1985:120;265-270.
  3. Bonelli U., Bettoli V., Masina M., Passarini B. Osservazioni sul granuloma facciale. Dermatologia Clinica 1985: V:191-196.
  4. Scorolli L., Martini E., Bettoli V., Pasini S. Acido 13-cis-retinoico e blefarite seborroica.Società oftalmologia italiana. 1985:281-292.
  5. Tosti A., Bettoli V., Tannini G., Forlani L. Contact urticaria from polypropylene. Contact Dematitis. 1986:15:51.
  6. Bettoli V., Tosti A. Leukonychia totalis and partialis: a single family presenting a peculiar course of disease. J.Am.Acad. Dermatol:1986:15:535.
  7. Bettoli V., Tosti A., Varotti C. Nummular eczema during isotretinoin treatment. J. Am. Acad. Dermatol.1987:16:617.
  8. Manuzzi P., Bettoli V., Negosanti M., Pizzino D. Iperplasia angiolinfoide con eosinofilia: presentazione di un caso clinico. Dermatologia Clinica 1987:VII:15-18.
  9. Bonelli U. Guerra L., Passarini B., Bettoli V. Vasculite orticarioide polisistemica. Giorn.It. Derm. Vener. 1987:122:629-632.
  10. Tosti A. Guerra L., Bettoli V., Bonelli U., Solid facial edema as a complication of acne vulgaris in twins. J. Am.Acad. Dermatol. 1987:17:843-844.
  11. Tosti A., Albisinni U., Bettoli V., Merlini L., Lama L. Ossification of the posterior longitudinal ligament associated with etretinate therapy. Dermatologica 1987:175:257-258.
  12. Bettoli V., Pizzino D., Varotti C. Trattamento con isotretinoina dell’acne nodulo-cistica conglobata. Cronica Dermatologica 1987:XVIII:515-521.
  13. Pizzino D., Bettoli V., Varotti C. Trattamento antiandrogeno dell’acne: validità di una terapia con spironolattone. Gion.It. Derm. Vener. 1987:122:599-604.
  14. Bonelli U. Guerra L., Bettoli V., Passarini B. Urticarial vasculitis with generalized pustular psoriasis and pseudotumor cerebri: a case report. Ann. It. Derm. Sper. 1988:42:171-176.
  15. Scorolli L., Godano A., Bettoli V., Pizzino D., Varotti C. Keratoconjonctivite seche en cours de traitment avec de l’acide 13-cis retinoique (isotretinoine). Ophtalmologie 1988 :2 :117-119.
  16. Tosti A., Bettoli V., Guerra L., Monelli U. Orticarie fisiche. Gli ospedali della vita. 1988:XV:22-25.
  17. Bettoli V., Bonelli U., Tosti A., Guerra L. Aspetti immunologici dell’orticaria. Cronica Dermatologica 1988:XIX:337-342.
  18. Bettoli V., Selvi M., Ferlini A., Pasi F., Patrizi A. Il multistest nella valutazione della immunità cellulare. Giorn.It.Derm. Vener.1989:124:197-201.
  19. Manuzzi P., Bettoli V., Bardazzi F., Tosti A. Leuconichia totale e parziale e leuconichia associata a koilonichia: descrizione di 4 casi.Chronica Dermatologica 1989:XX:697-701.
  20. Bettoli V., Bonelli U. Efficacia e tollerabilità dell’alclometasone nelle dermatosi steroido-sensibili. Giorn.It.Derm. Vener 1990:
  21. Bettoli V., Tosti A., Capobianco C., Varotti C. Creatin kinase values during isotretinoin treatment. Dermatologica 1990:180:54-56.
  22. Strumia R., Bettoli V., Marchetti F. Calcinosi cutanea con eliminazione trans-epiteliale in Porfiria cutanea tarda. Giorn.It. Derm. Vener. 1990:125:201-204.
  23. Bettoli V., D’Antuono A., Rumpianesi F., Cevenini R., Negosanti M. Nuovo test Elisa per la ricerca di Chlamydia trachomatis in pazienti con uretrite non-gonococcica. Dermatologia Oggi. 1990:4:34-36.
  24. Passarini B., Siviero G. A., Bettoli V., Capobianco C., Varotti C. Lupus miliare disseminato del volto. Boll.Soc. Med. Chir. Modenese 1990:90.205-207.
  25. Capobianco C., Bettoli V., Albisinni U., Merlini L., Vincenzi C. Isotretinoina – alterazioni ossee e legamentose. Giorn. It. Derm. Vener. 1991:126:291-293.
  26. Varotti C., Bettoli V., Berti E., Cavicchini S., Caputo R. Xanthoma disseminatum: a case with estensive mucous membrane involvement. J.Am. Acad. Dermatol: 1991:25:433.
  27. Bettoli V., Zampino R., Altieri E. Epitelioma cuniculatum: descrizione di un caso a localizzazione palmare. Giorn.It.Derm.Vener. 1991:126:579-582.
  28. Bettoli V., Altieri E., Zavarini G. Dermatite ipereosinofila. Giorn. It.Derm. Vener. 1991:126:551-554.
  29. Bettoli V., Neri I., Capobianco C., Gaddoni A.M., Bazzoli F. Acrodermite enteropatica acquisita. Giorn.It. Derm.Vener. 1991:126:557-560.
  30. Negosanti M., Giosa F., D’Antuono A., Bettoli V., Ghetti P., Camerino M., Rossi L., Varotti C. HPV infection of uterine cervix: natural history. Virus Infection in Dermatology (IV Symposium Augustanum) 1988:21-24.
  31. D’Antuono A., Negosanti M., Bettoli V., Gizzi G., Villani V., Cevenini R., Varotti C. Proctite da Chlamydia Trachomatis. Dermatology in Europe. 1989: 664-666.
  32. Bettoli V., Virgili A., Corazza M. Considerazioni sulla tinea capitis dell’adulto. Micologia Dermatologica 1991:5:79-85.
  33. Patrone P., Misciali M., Bettoli V., Fanti P. A. Cheratodermia palmo-plantare ereditaria epidermolitica:descrizione di un caso. Giorn. It. Derm. Vener. 1991:126:565-567.
  34. Desirello G., Bettoli V. Il cheratinocita nella eziopatogenesi e nella terapia della apsoriasi. Dermatologia Oggi. 1992:6:3-7.
  35. Bettoli V., Bigi A., Cojazzi G., Riveri N., Strumia R. Structural and chemical characterization of a cutaneous calcification. Journal of thermal analysis 38:2719.28:1992.
  36. Bettoli V., Romani I., Strumia R., Calatoci M., Sensi A. Naevomatose basocellulaire. Nouv. Dermatol. 11:827: 1992.
  37. Bettoli V., Mantovani L., Altieri E., Strumia R. Ofuji Papuloerythroderma: report of a European case. Dermatology 186:187-189:1993.
  38. Bettoli V., Trimurti S., Leis M., Virgili A. Miasi cutanea da Tumbu fly (cordylobia anthropophaga): studio ultrastrutturale G. Ital. Dermatol Venereol. 128:243-6:1993.
  39. Bettoli V., Virgili A., Roveggio C. Le ittiosi congenite: attualità in tema di diagnosi prenatale e terapia. Regione Emilia Romagna – I.M.E.R. – News letter – 10,1993.
  40. Bettoli V., Virgili A., Zampino MR., Bedetti A., Montanari P. Cutaneous Cryptococcosis in AIDS: successful tretment with itraconazole. Mycoses. 1993 Nov-Dec;36(11-12):433-5.
  41. Pampiglione S., Bettoli V., Cestari G., Staffa M. Furuncular myiasis due to Cordylobia anthropophaga, endemic in the same locality for over 130 years. Ann Trop Med Parasitol. 1993 Apr;87(2):219-20.
  42. Pampiglione S., Bettoli V., Cestari G., Staffa M., Fioravanti M. Miasi da cordylobia anthropophaga: 7 casi su turisti italiani di ritorno dal Senegal. Annali Italiani di Dermatologia Clinica e Sperimentale 47:195-200:1993.
  43. Bettoli V., Mantovani L., La Malfa W. Ofuji Papuloerythroderma-pattern (OPP). Dermatology 100:189:1994.
  44. Corazza M, Mantovani L, Romani I, Bettoli V, Virgili A. Compound allergy to topical budesonide. Contact Dermatitis. 1994;30(4):246-7.
  45. Sensi A., Bettoli V., Zampino M.R., Gandini E., Calzolari E. Vohwinkel Syndrome (mutilating keratoderma) associated with cranio facial anomalies. Am. Journal of Medical Genetics 50:201-3:1994.
  46. Strumia R., Altieri E., Romani R., Bettoli V., Negrini A., Trimurti S. Tacalcitol in psoriasis: a video-microscopy study. Acta Derm.Venereol.(Stockh) 1994;186:85-7.
  47. Bettoli V., Virgili A., Saper prescrivere…etretinato. Dermotime 1994: 23;VI (2).
  48. Zavarini G., Bettoli V., La Malfa W., Manservigi D. Xantomatosi eruttiva: descrizione di un caso in un paziente affetto da sindrome polimetabolica. Cronica Dermatologica. 1995:2; 219-224.
  49. Bettoli V., Negrini A., Trimurti S., Altieri E. L’associazione etretinato-interferone alfa-2° a basse dosi nel trattamento della mucosi fungoide. G. Ital. Dermatol. Venereol. 1995:130;345-348.
  50. Gallerani M., Ricci L., Menozzi L., Bettoli V., Lombardi A., Manfredini R. Chemical Burns from intradermal self – administration of muriatic acid : Am. J. Emerg: Med: 1996;14:539-40.
  51. Bettoli V., Pazzaglia M., La Malfa W., R. Strumia. Osservazioni preliminari sull’impiego dell’acido cogico nel cloasma. Dermatologia Ambulatoriale 1996; IV:n2: 15-17.
  52. Bettoli V. et. al. Effetti collaterali da peeling con acido glicolico: esperienza personale. Annali Italiani di dermatologia clinica e sperimentale. 50; 178-181:1996.
  53. Bettoli V., Trovato C., La Malfa W., Pazzaglia M. Vasculite allergica in corso di ORF. G. Ital. Dermatol.Venereol. 1997;132:39-42.
  54. Bettoli V., Bertelli G., Lombardi A.R.,. Pollini V, Virgili A.. Actinomicosi: descrizione di due casi. G. Ital. Dermatol. Venereol. 1997; 132:199-201.
  55. Bettoli V., De Padova M.P., Corazza M., A. Virgili. Generalized Lichen Nitidus with oral and nail involvement in a child. Dermatology. 1997;194:367-369.
  56. Bettoli V., Virgili A. In tema di isotretinoina. G.It. Dermatol. Venereol. 1997; 132: 227-229.
  57. Bettoli V., Virgili A. Le nuove linee guida canadesi per la diagnosi e la terapia dell’acne. Valutazioni e commenti. G. It.Dermatol. 1997;132: 464-466.
  58. Gallerani M., Bettoli V., Peron L., Manfredini R. Systemic and topical effects due to intradermal hydrofluoric acid. Am. J. Emerg. Med. 1998;16(5):521-2.
  59. Stabellini N., Camerani A., Lambertini D., Rossi M.R., Bettoli V., Virgili A., Gilli P. Fatal sepsis from Vibrio Vulnificus in a Hemodialyzed Patient. Nephron 1998; 78: 221-224.
  60. Bettoli V., Trimurti S, Lombardi A., Virgili A. Acne due to a amineptine abuse. J Eur Acad Dermatol Venereol.1998;10:281.
  61. Bettoli V. Lombardi A.R., Pazzaglia M., Virgili A. Isotretinoina ed acne grave: esperienza personale di recidive dopo un lungo periodo di follow up. G.It.Dermatol. Venereol. 1998:133:333-6.
  62. Bettoli V., Bertelli G., Lombardi A., Pazzaglia M. Porfiria cutanea tarda. Correlazione con l’infezione da HCV. G. Ital. Dermatol. Venereol.1998;133: 105-107.
  63. Corazza M., Bertelli G., Bettoli V., Altieri E., Virgili A. Intertrigine dei piedi da Gram-negativi. G. Ital. Dermatol. Venereol. 1998; 133: 101-104.
  64. Tosti A., Piraccini B.M., D’Antuono A., Marzaduri S., Bettoli V. Paronychia associated with antiretroviral therapy. Br J Dermatol 1999, 140: 1165-1168.
  65. Bettoli V., Tosti G., Panigalli S., Virgili A. Problemi terapeutici nell’acne nodulo cistica e conglobata. G. It. Dermatol. Venereol. 1999; 134: 675-678.
  66. Bettoli V., Tosti G., Levratti A., Panigalli S., Carlà E., Virgili A. La gestione del paziente in trattamento con retinoidi sistemici. G It Derm Venereol 2000;135 (Suppl. 2 al n.5): 3-9.
  67. Tosti G., Bettoli V., Carlà E., Virgili A. Efficacia di isotretinoina sistemica in una paziente epilettica con rosacea fulminans. G It Dermatol Venereol 2000;135:276-275.
  68. Bettoli V., Panigalli S. Tosti G., Levratti A., Virgili A. L’acne in età pediatrica. Dermotime. 2001; 13(4); 17-20.
  69. Virgili A., Zampino M.R., Bacilieri S., Bettoli V., Chiarelli M. Squamous cell carcinoma of the nail bed: a rare disease or only misdiagnosed ? Acta Dermatovenereol. 2001:81(4);306-7.
  70. Baccarini Contri M., Baccelli B., Boraldi F., Quaglino D., Tarapelli F., Carnevali E., Francomano M.A., Seidenari S., Bettoli V., De Sanctis V., Pasquali –Ronchetti I. Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia. Journal Am. Acad. Dermatol. 2001; 44:33-9.
  71. Tosti G., Bettoli V., Virgili A., Rossi M.R., Altieri E. A long-lasting verrucous plaque on the hand revealed as tuberculosis cutis. Acta Derm Venereol. 2001:81(6);448-9.
  72. Bettoli V. Processo patogenetico e trattamento con retinoidi. In: Novità terapeutiche nell’acne. Medical Symposia. 2001:32;2.
  73. Virgili A., Tosti G., Bettoli V., Corazza M. Multiple congenital symmetric skin dimples. Dermatology 2002:204;293-95.
  74. Bettoli V., Ferroni M., Pizzigoni S., Virgili A. L’isotretinoina orale nelle malattie sistemiche. Dermatologia Ambulatoriale 2002;X:56-60.
  75. Bettoli V., Tosti G., Virgili A. Eritromicina 2% + isotretinoina 0,05% gel vs eritromicina 3% + zinco lozione: valutazione comparativa split-face per efficacia e tollerabilità in pazienti acneici. G.Ital.Dermatol.Venereol. 2002:137:363.
  76. Bettoli V. Oral Antibiotics in acne. Acne Brief. 2002; 2.
  77. Bettoli V, Borghi A, Carlà E, Trincone S, Pizzigoni S, Virgili A. Il problema delle cicatrici postacneiche: inquadramento diagnostico e terapeutico. Dermatologia Ambulatoriale 2002; 3: 53-9.
  78. Bettoli V., Ferroni M., Virgili A., Rossi R. P.Acnes e antibiotico-resistenza: un fenomeno emergente. Dermotime 2002;4:5.
  79. Bettoli V. Aggiornamento sull’acne: patogenesi e approccio terapeutico. Acta Pharmacologica 2003;VII:6-14.
  80. Rossi MR., Baldrati M., Catapano V., Giovannini G., Bettoli V., Ferroni M. Valutazione dell’antibiotico resistenza nell’acne. Microbiologia Medica 2003;18:279-282.
  81. Bettoli V, Borghi A, Pizzigoni S, Ferroni M, Virgili A. Benzoil perossido: cent’anni ma non li dimostra. La Pelle 2003; 9: 39-41.
  82. Ross JI., Snelling AM., Carnagie E., Coates P., Cunliffe WJ., Bettoli V., Tosti G., Katsambas A., Galvan Perez del Pulsar JI., Rollman O., Torok L., Eady EA., Cove JH. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148(3):467-78.
  83. Gollnick H., Cunliffe WJ., Berson D., Leyden J., Dreno B., Shalita A., Finlay A., Thiboutot D., Bettoli V., et al. Management of Acne. A Report from a Global Alliance to improve outcomes in Acne. JAAD 2003;49:S1.
  84. Andreassi L., Barba F., Bettoli V., Cerimele D., et al. Open observational study on the efficacy and tolerability of Tetralysal for moderate-to-severe acne vulgaris with a major inflamatory component. Dermatological Experiences. 2003;V:319-324.
  85. Bettoli V, Ferroni M, Pizzigoni S, Borghi A, Virgili A. Isotretinoina sistemica: considerazioni sugli effetti collaterali e sull’utilizzo in condizioni particolari. Dermatologia Ambulatoriale 2003; XI: 56-60.
  86. Bettoli V, Borghi A, Pizzigoni S, De Sanctis V, Virgili A. Oral isotretinoin for severe acne in beta-Thalassemia major. Dermatology 2004; 208: 360-1.
  87. Bettoli V., Pizzigoni S., Vasina S., Mancino A., Virgili A. Oral isotretinoin and haemophilia A. J Eur Acad Dermatol Venereol. 2004;18(6):718-20.
  88. Bettoli V, Pizzigoni S, Borghi A, Virgili A. Ofuji papulo-erythroderma: a reappraisal of the deck-chair sign. Dermatology 2004; 209: 1-4. (Editorial)
  89. Dreno B., Bettoli V., Ochsendorf F., Layton A., Mobacken H., Degreef H.; European Export Group on Oral Antibiotics in Acne. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004;14(6):391-9.
  90. Bettoli V, Borghi A, Virgili A. La ghiandola sebacea e il suo ruolo nella patogenesi dell’acne. Rivista Italiana di Medicina dell’Adolescenza 2005; 3:32-5.
  91. Bettoli V, Borghi A, Ferroni M, Rossi R, Virgili A. Antibiotic resistance of propionibacteria. Four years’ experience of a large number of cases in Italy. Dermatology 2006; 212: 206-7.
  92. Bettoli V, Borghi A, Mantovani L, Virgili A. La nuova regolamentazione per la prevenzione della gravidanza in corso di terapia con isotretinoina orale in Italia. Dermoflash 2006; n.1.
  93. Bettoli V, Borghi A, Mantovani L, F.Osti, Virgili A. Considerazioni sulle nuove indicazioni della isotretinoina orale. Dermoflash 2006; n.2
  94. Bettoli V, Borghi A, Rossi R, Ferroni M, Rigolin F, Virgili A. Personal experience on antibiotic resistance in Ferrara. G Ital Dermatol Venereol 2006; 141: 117-22.
  95. Bettoli V, Mantovani L, Borghi A. Una nuova associazione terapeutica topica per l’acne in Italia: clindamicina 1% + benzoilperossido 5%. Journal of Acne and Related Disorders. Anno I, Vol. 1, Maggio/Agosto 2006;12-15.
  96. Bettoli V, Borghi A, Mantovani L. Il trattamento dell’acne in estate: un dilemma che si ripropone. Il Medico Informato 2006; Dogma srl.
  97. Bettoli V, Borghi A, Virgili A. Acne volgare: linee guida al trattamento. Rivista Italiana di Medicina dell’Adolescenza. 2006;4:23
  98. Bettoli V., Mantovani L., Boccia S., Virgili A. Rosacea Fulminans related to Pegylated Interferon Alpha-2b and Ribavirin therapy. Acta Dermato Venereol. 2006:86:258.
  99. Bettoli V, Osti F, Rossi R, Borghi A, Mantovani L, Virgili A. Follicolite da Gram negativi. Journal of Acne and Related Disorders. Anno I, Vol. 2, Settembre/Dicembre 2006: 6-9.
  100. Bettoli V, Borghi A, Mantovani L. Isotretinoina orale e coinvolgimento epatico. Dermoflash 2006; n.3.
  101. Bettoli V., Borghi A., Mantovani L., Osti F., Virgili A. L’acne volgare: guida al trattamento. Rivista italiana di medicina dell’adolescenza. 2006: 4; 84.
  102. Dréno B., Bettoli V., Ochsendorf F., Perez-Lopez M., Mobacken H, Degreef H., Layton A. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol. 2006 Sept-Oct;16(5):565-71.
  103. Bettoli V., Mantovani L., Borghi A., Ferroni M., Virgili A. Adapalene 0.1% cream after oral isotretinoin: evaluation of the acne recurrence incidence. International Proceedings – Medimont 2006;351-355.
  104. Bettoli V., Borghi A., Mantovani L., Osti F., Virgili A. Terapia topica dell’acne: abbiamo bisogno di novità ? Journal of Acne and Related Disorders 2006;I:3.
  105. Veraldi S., Barbareschi M., Innocenzi D., Bettoli V., Micali G., Fabbrocini G., Monfrecola G. (Italian Acne Board). Trattamento dell’acne lieve-moderata con acido azelaico al 15% in gel: risultati preliminari di uno studio italiano, multicentrico, pilota, aperto. Journal of Acne and Related Disorders 2007;II:2.
  106. Borghi A, Mantovani L, Virgili A, Bettoli V. Acne inversa: patologia complessa e sfida terapeutica. Journal of Acne and Related Disorders. Anno II, Vol. 4, Maggio/Agosto 2007: 17-20
  107. Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Terapia antibiotica dell’acne volgare: potenziale ruolo del dermatologo nella selezione di resistenza all’interno della flora batterica residente. Journal of Acne and Related Disorders. Anno III, Vol. 6, Gennaio/Aprile 2008: 2-10.
  108. Bettoli V, Borghi A, Mantovani L, Minghetti S, Virgili A. La patogenesi dell’acne. L’acné, quoi de neuf? Supplemento n1 all’edizione francese 2008: 10-9.
  109. Mantovani L, Bettoli V, Barbareschi M, Borghi A, Fabbrocini G, Innocenzi D, Micali G, Monfrecola G, Veraldi S. Associazione topica fissa benzoil perossido clindamicina: efficacia e tollerabilità clinica. Esperienza preliminare presso vari centri dell’Italian Acne Board. Journal of Acne and Related Disorders. Anno III, Vol. 8, Settembre/Dicembre 2008: 10-14.
  110. Borghi A, Mantovani L, Bettoli V. Acne: problemi e soluzioni. Il parere del dermatologo. Il Medico Informato 2008; Dogma srl
  111. Gollnick HP., Finlay AY., Shear N; Global Alliance to Improve Outcomes in Acne. Can we define acne as a chronic disease ? If so, how and when ? Am J Clin Dermatol 2008;9(5):279-84.
  112. Gridelli C., Maione P., Amoroso D., Baldari M., Bearz A., Bettoli V., Camilluzzi E., Crinò L., De Marinis F., Di Pietro FA., Grossi F., Innocenzi D., Micali G., Piantedosi FV., Scarrozzi M. Clinical significance and treatment of skin rash from erlotinib in non small cell lung cancer patients: results of an Experts Panel Meeting. Crit Rev Oncol Hematol. 2008 May;66(2):155-62.
  113. Borghi A., Mantovani L., Bettoli V. Acne: esigenza di una gestione adeguata. Dermatologia Ambulatoriale 2008;XVI: 43-50.
  114. Borghi A, Mantovani L, Minghetti S, Zauli S, Virgili A, Bettoli V. L’infiammazione nell’acne: il ruolo di Propionibacterium acnes. Journal of Acne and Related Disorders. Anno IV, Vol. 9, Gennaio/Aprile 2009
  115. Bettoli V., Borghi A., Mantovani L., Minghetti S., Scorrano R., Zauli S., Virgili A. Pseudotumor cerebri indotto da minociclina: descrizione di due casi clinici. Journal of Acne and Related Disorders 2009; IV: vol. 10, 17.
  116. Fabbrocini G., De Vita V., Pastore F., Barbareschi M., Bettoli V., Innocenzi D., Micali G., Monfrecola G., Veraldi S. Il trattamento di cicatrici post-acneiche di tipo ipertrofico mediante l’utilizzo di un gel siliconico: due anni di esperienza. Journal of Acne and Related Disorders 2009; IV: vol. 11, 33.
  117. Veraldi S., Barbareschi M., Fabbrocini G., Innocenzi D., Bettoli V., Micali G., Monfrecola G., Schianchi R. Trattamento dell’acne lieve-intermedia con nicotinamide topica. Risultati di due studi clinici italiani multicentrici – I parte. Journal of Acne and Related Disorders 2009; IV: vol. 11, 26.
  118. Fabbrocini G., De Vita V., Pastore F., Barbareschi M., Bettoli V., Innocenzi D., Micali G., Monfrecola G., Veraldi S. I retinoidi topici nella prevenzione e nel trattamento degli esiti cicatriziali post-acneici. Journal of Acne and Related Disorders 2009; IV: vol. 11, 8.
  119. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita AR, Lozada VT, Berson D, Finlay A, Goh CL, Herane MI, Kaminsky A, Kubba R, Layton A, Miyachi Y, Perez M, Martin JP, Ramos-E-Silva M, See JA, Shear N, Wolf J Jr; Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009 May;60(5 Suppl):S1-50. Review
  120. Fabbrocini G., Cacciapuoti S., Barbareschi M., Bettoli V., et al. Il trattamento medico delle cicatrici postacneiche. Journal of Acne and Related Disorders. 2009;IV:15.
  121. Cianchini G., Veller Fornasa C., Lupi F., Amato S., Bellosta M., Bergamo F., Bettoli V., et al. Definizione di malattia, endpoint e risposta terapeutica nel pemfigo: International Consensus. Statement e raccomandazioni GIDI e GIPMO. Esperienze Dermatologiche 2009;11:3
  122. Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Acute acne flare following isotretinoin administration: potential protective role of low starting dose. Dermatology 2009; 218:178-80.
  123. Layton A., Bettoli V., Miyachi Y., Dreno B., Perez M., Leyden JJ. The changing role of antibiotics in managing acne. JAAD 2009;60:S6
  124. Gollnick H., Bettoli V., Thiboutot D., Leyden JJ. The role of topical retinoids in acne maintenance therapy. JAAD 2009;60:S25
  125. Dreno B., Goh CL., Kubba R., Ramos-e-Silva M., Bettoli V. Managing of acne scarring. JAAD 2009;60:S32.
  126. Dreno B, Thiboutot D, Gollnick H, Finlay AY, Layton A, Leyden JJ, Leutenegger E, Perez M; Global Alliance to Improve Outcomes in Acne. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010 Apr;49(4):448-56.
  127. Corazza M., Minghetti S., Zauli S., Ricci M., Bettoli V. Asymptomatic brownish reticolate patch onthe left thigh: a quiz. Acta Derm. Veneriol. 2010; 90: 555-558.
  128. Bettoli V. Eziopatogenesi dell’acne. Rivista della Società Italiana di Medicina Generale. 2010; 2: 33-38.
  129. Leyden JJ, Gollnick H, Thiboutot D, Dreno B, Bettoli V, Kang S, Shalita A, Torres V. The hypothetical role of Fox01 in acne is interesting, but more study is needed before any conclusions can be drawn. Br J Dermatol 2010; 163(6):1365-6, author reply 1366-7.
  130. Bettoli V. Acne: domande e risposte. One Global Medicine. 2010;
  131. Bettoli V., Sarno O., Zauli S., Borghi A., Ricci M., Mantovani L., Toni G., Virgili A. What’s new in acne ? New therapeutic approaches. Annales de Dermatologie. 2010; 137: S81-S85.
  132. Pelfini C., Bettoli V. Terapia medica della rosacea. Dermatologia ambulatoriale 2010. XVIII; 13.
  133. Bettoli V. Simposio Nazionale su “Acne e cioccolato” Esperienze dermatologiche 2010; 2: 121.
  134. Bettoli V, Borghi A, Mantovani L, Scorrano R, Minghetti S, Toni G, Sarno O, Zauli S, Virgili A. Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline. Eur J Dermatol. 2011 Nov-Dec;21(6):1024-5.
  135. Dréno B, Kaufmann R, Talarico S, Torres Lozada V, Rodríguez-Castellanos MA, Gómez-Flores M, De Maubeuge J, Berg M, Foley P, Sysa-Jedrzejowska A, Kerrouche N, Paliargues F, Bettoli V. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study. Br J Dermatol. 2011 Aug;165(2):383-90.
  136. Borghi A, Mantovani L, Minghetti S, Giari S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1094-8.
  137. Di Landro A, Cazzaniga S, Parazzini F, Ingordo V, Cusano F, Atzori L, Cutrì FT, Musumeci ML, Zinetti C, Pezzarossa E, Bettoli V, Caproni M, Lo Scocco G, Bonci A, Bencini P, Naldi L; GISED Acne Study Group. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol. 2012 Feb 29.
  138. Zauli S, Virgili A, Bettoli V. Objective evaluation of atrophic post-acne scars: available techniques. Journal of Plastic Dermatology 2011;7:3.
  139. Zauli S, Sarno O, Borghi a, Ricci M,Toni G, Virgili A, Bettoli V. La biopsia del corneo nello studio dei comedoni. Hi.tech Dermo 2011;6:47.
  140. Borghi A, Bettoli V, Sarno O, Minghetti S, Zauli S, Toni G, Virgili A. Un concetto emergente nellacura dell’acne: la terapia di mantenimento. Rivista Italiana di Medicina dell’Adolescenza 2011;9:14.
  141. Finlay AY, Torres V, Kang S, Bettoli V, Dreno B, Goh CL, Gollnick H; On behalf of the Global Alliance. Classification of acne scars is difficult even for acne experts. J Eur Acad Dermatol Venereol. 2012 Feb 14
  142. Colina M, Bettoli V, Pretolani S, Zauli S, Govoni M, Arienti V. “Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome”: comment on the article by Zhao et al. J Dermatol. 2012 Jul;39(7):659-60.
  143. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita A, Torres V; Global Alliance to Improve Outcomes in Acne. Oral isotretinoin and pregnancy prevention programmes. Br J Dermatol. 2012 Feb;166(2):466-7
  144. Nast A, Dréno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, Ganceviciene R, Haedersdal M, Layton A, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Rzany B, Sammain A, Simonart T, Veien NK, Zivković MV, Zouboulis CC, Gollnick H; European Dermatology Forum.European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012 Feb;26 Suppl 1:1-29.
  145. Bettoli V, Zauli S, Toni G, Virgili A Onychomadesis following hand, foot, and mouth disease: a case report from Italy and review of the literature. Int J Dermatol. 2013 June;52:728-30.
  146. Veraldi S, Giovene GL, Guerriero C, Bettoli V. Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne. G Ital Dermatol Venereol. 2012 Oct;147(5):491-7.
  147. Fabbrocini G, Annunziata MC, Skroza N, Bettoli V, Moftah N, May el-Samahy, Mokos ZB, Barbareschi M, Veraldi S, Micali G, Bruno F, Monfrecola G. Epidemiologia dell’acne: oltre i dati europei. European Journal of Acne and Related Disorders 2012;3:31
  148. Bettoli V. Che cosa dicono le Linee Guida Europee (S3) per il trattamento dell’acne. Media Med Edizioni Scientifiche 2012.
  149. Zauli S, Virgili A, Bettoli V. In vitro report and in vivo investigation of adjuvant topical treatment of acneic skin based on micronized silver, zinc acetate and lauric acid. European Journal of Acne and Related Disorders 2013;4:1.
  150. Bettoli V, Zauli S, Virgili A. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how. J Dermatolog Treat. 2013 Jun;24(3):235-7. doi: 10.3109/09546634.2012.746634. Epub 2013 Feb 3.
  151. Bettoli V, Minghetti S, Ferron P, Borghi A, Virgili A. Solitary hypertrophic lupus erythematosus of the nose without other cutaneous or systemic involvement. Int J Dermatol. 2014 Jan;53(1):e18-20. doi: 10.1111/j.1365-4632.2011.05349.x. Epub 2012 Dec 11. No abstract available.
  152. Zauli S, Caracciolo S, Borghi A, Ricci M, Giari S, Virgili A, Bettoli V. Which factors influence quality of life in acne patients? J Eur Acad Dermatol Venereol. 2014 Jan;28(1):46-50. doi: 10.1111/jdv.12053. Epub 2012 Dec 14.
  153. Bettoli V, Zauli S, Borghi A, Toni G, Minghetti S, Ricci M, Virgili A. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. J Eur Acad Dermatol Venereol. 2014 Jan;28(1):125-6. doi: 10.1111/jdv.12127. Epub 2013 Mar 2. No abstract available.
  154. Bettoli V, Zauli S, Virgili A, Gafà R. Eczematide-like purpura presenting as Ofuji papuloerythroderma: a case that confirms this as a pattern. Int J Dermatol. 2014 Feb;53(2):e132-4. doi: 10.1111/j.1365-4632.2012.05645.x. Epub 2013 Apr 4. No abstract available.
  155. Bettoli V, Borghi A, Zauli S, Toni G, Ricci M, Giari S, Virgili A. Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature. Dermatology. 2013;227(2):97-102. doi: 10.1159/000350820. Epub 2013 Sep 11. Review.
  156. Thiboutot D, Dreno B, Gollnick H, Bettoli V, Kang S, Leyden JJ, Shalita A, Torres V; Global Alliance to Improve Outcomes in Acne. A call to limit antibiotic use in acne. J Drugs Dermatol. 2013 Dec;12(12):1331-2. No abstract available.
  157. Vertuani S, Cvetkovska AD, Zauli S, Virgili A, Manfredini S, Bettoli V.The topical vehicle as a key factor in the management of the psoriatic patients’ therapy. G Ital Dermatol Venereol. 2013 Dec;148(6):679-85. Review.
  158. Bettoli V, Zauli S, Montis A, Ruina G, Virgili A. Acneiform eruption due to vitamin B12: a problem still unsolved. G Ital Dermatol Venereol. 2014 Feb;149(1):153-5. No abstract available.
  159. Dréno B, Bettoli V, Ochsendorf F, Layton AM, Perez M, Dakovic R, Gollnick H. Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies. Eur J Dermatol. 2014 Mar-Apr;24(2):201-9. doi: 10.1684/ejd.2014.2293.
  160. Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, Shalita A, Torres V; Global Alliance to Improve Outcomes in Acne. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol. 2014 May-Jun;24(3):330-4. doi: 10.1684/ejd.2014.2309. Review.
  161. Mantovani L, Zauli S, Toni G, Noto S, Bettoli V, Virgili A. Cutaneous plaques and ulnar neuropathy: challenge. Am J Dermatopathol. 2014 May;36(5):420-1, 439. doi: 10.1097/DAD.0000000000000014. No abstract available.
  162. Bettoli V, Zauli S. The epidemiology and comorbidities of severe acne in children aged 0-17 years. Br J Dermatol. 2014 May;170(5):1013-4. doi: 10.1111/bjd.13043. No abstract available.
  163. Ricci M, Zauli S, Zelante A, Trevisani L, Virgili A, Bettoli V. Bullous pemphigoid occurring under anti-tumor necrosis factor-α therapy. Int J Colorectal Dis. 2014 Dec;29(12):1573-4. doi: 10.1007/s00384-014-1924-9. Epub 2014 Jun 24. No abstract available.
  164. Manfredini M, Mazzaglia G, Ciardo S, Farnetani F, Mandel VD, Longo C, Zauli S, Bettoli V, Virgili A, Pellacani G. Acne: in vivo morphologic study of lesions and surrounding skin by means of reflectance confocal microscopy. J Eur Acad Dermatol Venereol. 2015 May;29(5):933-9. doi: 10.1111/jdv.12730. Epub 2014 Sep 26.
  165. Dréno B, Thiboutot D, Layton AM, Berson D, Perez M, Kang S; Global Alliance to Improve Outcomes in Acne. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1096-106. doi: 10.1111/jdv.12757. Epub 2014 Oct 8.
  166. Grossi E, Cazzaniga S, Crotti S, Naldi L, Di Landro A, Ingordo V, Cusano F, Atzori L, Tripodi Cutrì F, Musumeci ML, Pezzarossa E, Bettoli V, Caproni M, Bonci A; GISED Acne Study Group. The constellation of dietary factors in adolescent acne: a semantic connectivity map approach. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):96-100. doi: 10.1111/jdv.12878. Epub 2014 Dec 2.
  167. Zouboulis CC, Bettoli V. Management of severe acne. Br J Dermatol. 2015 Jul;172 Suppl 1:27-36. doi: 10.1111/bjd.13639. Review.
  168. Bettoli V, Zauli S, Virgili A. Is hormonal treatment still an option in acne today? Br J Dermatol. 2015 Jul;172 Suppl 1:37-46. doi: 10.1111/bjd.13681. Review.
  169. Veraldi S, Barbareschi M, Guanziroli E, Bettoli V, Minghetti S, Capitanio B, Sinagra JL, Sedona P, Schianchi R. Treatment of mild to moderate acne with a fixed combination of hydroxypinacolone retinoate, retinol glycospheres and papain glycospheres. G Ital Dermatol Venereol. 2015 Apr;150(2):143-7.
  170. Bettoli V, Toni G, Zauli S, Virgili A. Acne mechanica: probable role of IL-1α. G Ital Dermatol Venereol. 2016 Dec;151(6):720-721. Epub 2015 Apr 16. No abstract available.
  171. Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry. Bettoli V, Naldi L, Cazzaniga S, Zauli S, Atzori L, Borghi A, Capezzera R, Caproni M, Cardinali C, De Vita V, Donini M, Fabbrocini G, Gimma A, Pasquinucci S, Patrizi A, Pinna AL, Raone B, Ricci M, Virgili A, Balestri R. Br J Dermatol. 2016 Jan;174(1):195-7. doi: 10.1111/bjd.13864. Epub 2015 Nov 8. No abstract available. Erratum in: Br J Dermatol. 2017 Jun;176(6):1678.
  172. Dreno B, Gollnick HP, Kang S, Thiboutot D, Bettoli V, Torres V, Leyden J; Global Alliance to Improve Outcomes in Acne. Understanding innate immunity and inflammation in acne: implications for management. J Eur Acad Dermatol Venereol. 2015 Jun;29 Suppl 4:3-11. doi: 10.1111/jdv.13190. Review.
  173. Dreno B, Bettoli V, Perez M, Bouloc A, Ochsendorf F. Cutaneous lesions caused by mechanical injury. Eur J Dermatol. 2015 Apr;25(2):114-21. Review.
  174. De Pita’ O, Battarra V, Bellosta M, Bettoli V, Cristaudo A, Cusano F, Nobile C, Pellicano R, Ricciuti F, Simonetti S, Zichichi L, Sedona P. An update on topical treatment in psoriasis. Journal of Plastic Dermatology 2015,11:69.
  175. Bettoli V, Ricci M, Zauli S, Virgili A. Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients. Br J Dermatol. 2015 Nov;173(5):1328-30. doi: 10.1111/bjd.13951. Epub 2015 Aug 31. No abstract available.
  176. Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, Zarchi K, Antoniou C, Matusiak L, Lim HW, Williams M, Kwon HH, Gürer MA, Mammadova F, Kaminsky A, Prens E, van der Zee HH, Bettoli V, Zauli S, Hafner J, Lauchli S, French LE, Riad H, El-Domyati M, Abdel-Wahab H, Kirby B, Kelly G, Calderon P, del Marmol V, Benhadou F, Revuz J, Zouboulis CC, Karagiannidis I, Sartorius K, Hagströmer L, McMeniman E, Ong N, Dolenc-Voljc M, Mokos ZB, Borradori L, Hunger RE, Sladden C, Scheinfeld N, Moftah N, Emtestam L, Lapins J, Doss N, Kurokawa I, Jemec GB. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015 Dec;173(6):1546-9. doi: 10.1111/bjd.14038. Epub 2015 Nov 3. No abstract available.
  177. Daxhelet M, Suppa M, Benhadou F, Djamei V, Tzellos T, Ingvarsson G, Boer J, Martorell A, Ingram JR, Desai N, Nassif A, Revuz J, Hotz C, Bettoli V, Deckers IE, Jemec GB, Prens E, Zouboulis CC, Del Marmol V. Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software. J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1424-6. doi: 10.1111/jdv.13267. Epub 2015 Sep 15. No abstract available.
  178. Anderson MD, Zauli S, Bettoli V, Boer J, Jemec GB. Cyclosporine treatment of severe Hidradenitis suppurativa–A case series. J Dermatolog Treat. 2016;27(3):247-50. doi: 10.3109/09546634.2015.1088128. Epub 2015 Sep 25.
  179. Megna M, Bettoli V, Chimenti S, Chiricozzi A, Naldi L, Virgili A, Girolomoni G, Monfrecola G. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. G Ital Dermatol Venereol. 2015 Dec;150(6):731-9.
  180. Bettoli V, Join-Lambert O, Nassif A. Antibiotic Treatment of Hidradenitis Suppurativa. Dermatol Clin. 2016 Jan;34(1):81-9. doi: 10.1016/j.det.2015.08.013. Review.
  181. Layton A, Dréno B, Finlay AY, Thiboutot D, Kang S, Lozada VT, Bourdès V, Bettoli V, Petit L, Tan J. New Patient-Oriented Tools for Assessing Atrophic Acne Scarring. Dermatol Ther (Heidelb). 2016 Jun;6(2):219-33. doi: 10.1007/s13555-016-0098-5. Epub 2016 Feb 17. Erratum in: Dermatol Ther (Heidelb). 2016 Jun;6(2):235-6.
  182. Bettoli V, Zauli S, Borghi A, Toni G, Ricci M, Bertoldi AM, Virgili A. Efficacy and safety of a 12-month treatment with a combination of hydroxypinacolone retinoate and retinol glycospheres as maintenance therapy in acne patients after oral isotretinoin. G Ital Dermatol Venereol. 2017 Feb;152(1):13-17. doi: 10.23736/S0392-0488.16.05201-9. Epub 2016 Feb 18.
  183. Layton A, Dréno B, Finlay AY, Thiboutot D, Kang S, Lozada VT, Bourdès V, Bettoli V, Petit L, Tan J. Erratum to: New Patient-Oriented Tools for Assessing Atrophic Acne Scarring. Dermatol Ther (Heidelb). 2016 Jun;6(2):235-6. doi: 10.1007/s13555-016-0107-8. No abstract available.
  184. Dréno B, Lambert J, Bettoli V. Are retinoid/antibiotic fixed-dose combination acne treatments associated with antibiotic resistance? Eur J Dermatol. 2016 Jan-Feb;26(1):90-1. doi: 10.1684/ejd.2015.2654. No abstract available.
  185. Bettoli V, Zauli S, Virgili A. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment? G Ital Dermatol Venereol. 2016 Apr;151(2):216-8. No abstract available.
  186. Dréno B, Tan J, Kang S, Rueda MJ, Torres Lozada V, Bettoli V, Layton AM. How People with Facial Acne Scars are Perceived in Society: an Online Survey. Dermatol Ther (Heidelb). 2016 Jun;6(2):207-18. doi: 10.1007/s13555-016-0113-x. Epub 2016 Apr 18.
  187. Bettoli V, Toni G, Ricci M, Zauli S, Virgili A. Hidradenitis suppurativa-acne inversa-like lesions complicating naevus comedonicus: second case supporting the mechanical stress as a triggering factor. G Ital Dermatol Venereol. 2016 Jun;151(3):306-7. No abstract available.
  188. Gollnick HP, Bettoli V, Lambert J, Araviiskaia E, Binic I, Dessinioti C, Galadari I, Ganceviciene R, Ilter N, Kaegi M, Kemeny L, López-Estebaranz JL, Massa A, Oprica C, Sinclair W, Szepietowski JC, Dréno B. A consensus-based practical and daily guide for the treatment of acne patients. J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1480-90. doi: 10.1111/jdv.13675. Epub 2016 May 14.
  189. Kang S, Lozada VT, Bettoli V, Tan J, Rueda MJ, Layton A, Petit L, Dréno B. New Atrophic Acne Scar Classification: Reliability of Assessments Based on Size, Shape, and Number. J Drugs Dermatol. 2016 Jun 1;15(6):693-702.
  190. Bettoli V, antonioli P, Barbareschi M, Bellosta M, Cammarata S, Di Pietro A, Drago L, Libanore M, Pelfini C, Petraglia S, Pravettoni C, Rossi R, skroza N, Toni G, Veraldi S, zauli S, Virgili A. Acne, terapia antibiotica e antibiotico-resistenza: la posizione dei dermatologi italiani. Dermatological Experiences 2016;18:34-7.
  191. Manfredini M, Greco M, Farnetani F, Mazzaglia G, Ciardo S, Bettoli V, Virgili A, Pellacani G. In vivo monitoring of topical therapy for acne with reflectance confocal microscopy. Skin Res Technol. 2017 Feb;23(1):36-40. doi: 10.1111/srt.12298. Epub 2016 Jun 8.
  192. Tugnoli S, Bettoli V, Agnoli C, Caracciolo S. Emotions and bodily experience in Hidradenitis Suppurative-Acne Inversa. Clin Ter. 2016 May-Jun;167(3):e55-62. doi: 10.7417/CT.2016.1934. Italian.
  193. Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, Finlay AY, Haedersdal M, Lambert J, Layton A, Lomholt HB, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Simonart T, Werner RN, Gollnick H. European evidence-based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1261-8. doi: 10.1111/jdv.13776. No abstract available.
  194. Bettoli V, Zauli S, Passarini B, Virgili A. Two Subcutaneous Nodules on the Pubis: Challenge. Am J Dermatopathol. 2016 Sep;38(9):685-6. doi: 10.1097/DAD.0000000000000328. No abstract available.
  195. Bettoli V, Zauli S, Passarini B, Virgili A. Two Subcutaneous Nodules on the Pubis: Answer. Am J Dermatopathol. 2016 Sep;38(9):711. doi: 10.1097/DAD.0000000000000327. No abstract available.
  196. Di Landro A, Cazzaniga S, Cusano F, Bonci A, Carla C, Musumeci ML, Patrizi A, Bettoli V, Pezzarossa E, Caproni M, Fortina AB, Campione E, Ingordo V, Naldi L; Group for Epidemiologic Research in Dermatology Acne Study Group. Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy. J Am Acad Dermatol. 2016 Dec;75(6):1134-1141.e1. doi: 10.1016/j.jaad.2016.06.060. Epub 2016 Aug 16.
  197. Mantovani L, Zauli S, Virgili A, Bettoli V. Rosacea fulminans or acute rosacea? Report of 5 cases and review of the literature. G Ital Dermatol Venereol. 2016 Oct;151(5):553-7. Review.
  198. Bettoli V, Pasquinucci S, Caracciolo S, Piccolo D, Cazzaniga S, Fantini F, Binello L, Pintori G, Naldi L. The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1965-1970. doi: 10.1111/jdv.13687. Epub 2016 May 2.
  199. Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R; European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017 Nov;177(5):1401-1409. doi: 10.1111/bjd.15748. Epub 2017 Oct 30.
  200. Quality of life measurement in acne. Position Paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec GB, Manolache L, Tzellos T, Sampogna F, Evers AWM, Dessinioti C, Marron SE, Bettoli V, van Cranenburgh OD, Svensson A, Liakou AI, Poot F, Szepietowski JC, Salek MS, Finlay AY. J Eur Acad Dermatol Venereol. 2018 Feb;32(2):194-208. doi: 10.1111/jdv.14585. Epub 2017 Oct 10. Review.
  201. Thiboutot DM, Dréno B, Abanmi A, Alexis AF, Araviiskaia E, Barona Cabal MI, Bettoli V, Casintahan F, Chow S, da Costa A, El Ouazzani T, Goh CL, Gollnick HPM, Gomez M, Hayashi N, Herane MI, Honeyman J, Kang S, Kemeny L, Kubba R, Lambert J, Layton AM, Leyden JJ, López-Estebaranz JL, Noppakun N, Ochsendorf F, Oprica C, Orozco B, Perez M, Piquero-Martin J, See JA, Suh DH, Tan J, Lozada VT, Troielli P, Xiang LF. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018 Feb;78(2 Suppl 1):S1-S23.e1. doi: 10.1016/j.jaad.2017.09.078. Epub 2017 Nov 8. Review.
  202. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. Charlton RA, Bettoli V, Bos HJ, Engeland A, Garne E, Gini R, Hansen AV, de Jong-van den Berg LTW, Jordan S, Klungsøyr K, Neville AJ, Pierini A, Puccini A, Sinclair M, Thayer D, Dolk H. Eur J Clin Pharmacol. 2018 Apr;74(4):513-520. doi: 10.1007/s00228-017-2398-9. Epub 2017 Dec 11.
  203. Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A. The influence of exposome on acne. J Eur Acad Dermatol Venereol. 2018 May;32(5):812-819. doi: 10.1111/jdv.14820. Epub 2018 Feb 15. Review.
  204. Molesini S, Urto F, Cvetkovska AD, Bettoli V, ValacchiG, PecorelliA, ManfrediniS, VertuaniS. Influences of the vehicle in the spreading and release of betamethasone. Ther Deliv. 2018 Feb 1;9(3):177-184. doi: 10.4155/tde-2017-0070.
  205. Petit L, Zugaj D, Bettoli V, Dreno B, Kang S, Tan J, Torres V, Layton AM, Martel P. Validation of 3D skin imaging for objective repeatable quantification of severity of atrophic acne scarring. Skin Res Technol. 2018 Nov;24(4):542-550. doi: 10.1111/srt.12464. Epub 2018 Mar 6.
  206. Rizzello F, Olivieri I, Armuzzi A, Ayala F, Bettoli V, Bianchi L, Cimino L, Costanzo A, Cristaudo A, D’Angelo S, Daperno M, Fostini AC, Galeazzi M, Gilio M, Gionchetti P, Gisondi P, Lubrano E, Marchesoni A, Offidani A, Orlando A, Pugliese D, Salvarani C, Scarpa R, Vecchi M, Girolomoni G. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease. Adv Ther. 2018 Apr;35(4):545-562. doi: 10.1007/s12325-018-0672-6. Epub 2018 Mar 7.
  207. Cazzaniga S, Naldi L, Damiani G, Atzori L, Patta F, Guidarelli G, Bettoli V. Validation of a visual-aided questionnaire for the self-assessment of hidradenitits suppurativa. J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1993-1998. doi: 10.1111/jdv.15050. Epub 2018 May 28.
  208. Chernyshov PV, Tomas-Aragones L, Manolache L, Svensson A, Marron SE, Evers AWM, Bettoli V, Jemec GB, Szepietowski JC. Which acne treatment has the best influence on health-related quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1410-1419. doi: 10.1111/jdv.15048. Epub 2018 Jun 7. Review.
  209. Chiricozzi A, Bettoli V, De Pità O, Dini V, Fabbrocini G, Monfrecola G, Musumeci ML, Parodi A, Sampogna F, Pennella A, Buzzulini F, Gualberti G, di Luzio Paparatti U, Atzori L. HIDRAdisk: an innovative visual tool to assess the burden of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e24-e26. doi: 10.1111/jdv.15122. Epub 2018 Jun 27. No abstract available.
  210. Bettoli V, Manfredini M, Calamo G, Forconi R, Bencivelli D, Mantovani L, Pellacani G, Corazza M. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience. Dermatol Ther. 2018 Nov;31(6):e12737. doi: 10.1111/dth.12737. Epub 2018 Oct 8. No abstract available.
  211. Pelfini C, Amandolagine G, Musmeci D, Bettoli V. Cortisonici in tutte le forme di acne ? Il Dermatologo 2018;2:15
  212. Bettoli V, Manfredini M, Massoli L, Carillo C, Barozzi A, Amendolagine G, Ruina G, Musmeci D, Libanore M, Curtolo A, Mantovani L, Contini C, Pellacani G, Corazza M. Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol. 2019 May;33(5):930-936. doi: 10.1111/jdv.15332. Epub 2019 Feb 19
  213. Marasca C, Masarà A, Annunziata MC, Bettoli V, Luciano MA, Fabbrocini G. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients’ compliance. Br J Dermatol. 2019 Apr;180(4):949. doi: 10.1111/bjd.17423. Epub 2019 Jan 1. No abstract available.
  214. Peris K, Lo Schiavo A, Fabbrocini G, Dini V, Patrizi A, Fusano M, Bianchi L, Guanziroli E, Guarneri C, Parodi A, Bertoldi A, Musumeci ML, Offidani A, Rongioletti F, Pistone G, Malara G, Potenza C, Casari A, Franchi C, Ardigò M, Cusano F, Stingeni L, Amerio P, Mancini LL, Prignano F, Deboli T, Gualberti G, Saragaglia V, Bettoli V. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019 Apr;33(4):766-773. doi: 10.1111/jdv.15425. Epub 2019 Mar 5.
  215. Thorlacius L, Garg A, Riis PT, Nielsen SM, Bettoli V, Ingram JR, Del Marmol V, Matusiak L, Pascual JC, Revuz J, Sartorius K, Tzellos T, van der Zee HH, Zouboulis CC, Saunte DM, Gottlieb AB, Christensen R, Jemec GBE. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa. Br J Dermatol. 2019 Sep;181(3):483-491. doi: 10.1111/bjd.17716. Epub 2019 Jun 6.
  216. Manfredini M, Bettoli V, Sacripanti G, Farnetani F, Bigi L, Puviani M, Corazza M, Pellacani G. The evolution of healthy skin to acne lesions: a longitudinal, in vivo evaluation with reflectance confocal microscopy and optical coherence tomography. J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1768-1774. doi: 10.1111/jdv.15641. Epub 2019 May 8.
  217. Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol. 2019 Apr 27;11(4):391-401. doi: 10.4254/wjh.v11.i4.391.
  218. Tugnoli S, Agnoli C, Silvestri A, Giari S, Bettoli V, Caracciolo S. Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa. J Clin Psychol Med Settings. 2019 Jun 20. doi: 10.1007/s10880-019-09640-4. [Epub ahead of print]
  219. Manfredini M, Giuliani AL, Ruina G, Gafà R, Bosi C, Zoppas E, Di Virgilio F, Bettoli V. The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study. Dermatology. 2019 Aug 27:1-8. doi: 10.1159/000502026. [Epub ahead of print]
  220. Bettoli V. Focus sui peeling per le cicatrici post-acne. La Pelle 2019;7:15.
  221. Bettoli V, Cazzaniga S, Scuderi V, Zedde P, Di Landro A, Naldi L; IRHIS Group. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates – Italian Registry Hidradenitis Suppurativa project 2. J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:4-6. doi: 10.1111/jdv.15826.
  222. Fabbrocini G, Marasca C, Megna M, Peris K; HS Quality of Life Study Group. Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:25-27. doi: 10.1111/jdv.15821.
  223. Bettoli V, Coutanceau C, Georgescu V. A Real-Life, International, Observational Study Demonstrating The Efficacy Of A Cosmetic Emulsion In The Supportive Care Of Mild-To-Moderate Facial Acne. Clin Cosmet Investig Dermatol. 2019 Oct 10;12:759-769. doi: 10.2147/CCID.S205170. eCollection 2019.
  224. Bettoli V, Guerra-Tapia A, Herane MI, Piquero-Martín J. Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience. Clin Cosmet Investig Dermatol. 2019 Dec 30;12:943-951. doi: 10.2147/CCID.S234231. eCollection 2019
  225. Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study. Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18983. [Epub ahead of print]
  226. Marzano AV, Chiricozzi A, Giovanardi G, Argenziano G, Bettoli V, Bianchi L, Dapavo P, Dini V, Fabbrocini G, Micali G, Offidani AM, Potenza C, Prignano F, Gualberti G, Saragaglia V, Rongioletti F Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore. J Eur Acad Dermatol Venereol. 2020 Mar 2. doi: 10.1111/jdv.16328. [Epub ahead of print]
  227. Riis PT, Saunte DM, Sigsgaard V, Villani AP, Guillem P, Pascual JC, Kappe NN, Vanlaerhoven AMJD, van der Zee HH, Prens EP, El-Domyati M, Abdel-Wahab H, Moftah N, Abdelghani R, Agut-Busquet E, Romaní J, Hlela C, van den Worm L, Bettoli V, Calamo G, Gürer MA, Beksaç B, Matusiak L, Glowaczewska A, Szepietowski JC, Emtestam L, Lapins J, Kottb HR, Fatani M, Weibel L, Theiler M, Delage-Toriel M, Lam TTH, Nassif A, Becherel PA, Dolenc-Voljc M, Doss N, Bouazzi D, Benhadou F, Del Marmol V, Jemec GBE. Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res. 2020 Mar 12. doi: 10.1007/s00403-020-02053-6. [Epub ahead of print]
  228. Dessinioti C, Zouboulis CC, Bettoli V, Rigopoulos D. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol. 2020 Apr 11. doi: 10.1111/jdv.16430. [Epub ahead of print] Review.